Search research articles
Contact Us
Filters
Showing results (191-200 of 602) with videos related to
Page
of 61
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 27, 2008
Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients
Paolo Barone, David J Burn, Teus van Laar, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 5, 2002
Application of the International Cooperative Ataxia Scale rating in multiple system atrophy
François Tison, Farid Yekhlef, Eric Balestre, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 18, 2011
Restless legs syndrome in Friedreich ataxia: a polysomnographic study
Birgit Frauscher, Sascha Hering, Birgit Högl, et al.
Journal of Neurology
|
September 22, 2006
Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : a double-blind placebo-controlled cross-over trial
Jörg Wissel, Tanja Haydn, Jörg Müller, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 9, 2002
Riluzole therapy in cervical dystonia
Jörg Müller, Gregor K Wenning, Jörg Wissel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 2, 2008
Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: a clinical pilot trial
Sylvia Boesch, Brigitte Sturm, Sascha Hering, et al.
Journal of Neurology
|
March 6, 2007
Progression of brain atrophy in multiple system atrophy. A longitudinal VBM study
Christian Brenneis, Karl Egger, Christoph Scherfler, et al.
Movement Disorders Clinical Practice
|
October 27, 2018
Elastic Abdominal Binders Attenuate Orthostatic Hypotension in Parkinson's Disease
Alessandra Fanciulli, Georg Goebel, Bernhard Metzler, et al.
Expert Review of Neurotherapeutics
|
February 2, 2023
Optimizing levodopa therapy, when and how? Perspectives on the importance of delivery and the potential for an early combination approach
Andrew Lees, Eduardo Tolosa, Fabrizio Stocchi, et al.
Parkinsonism & Related Disorders
|
July 6, 2022
Characterization and diagnostic potential of R<sub>2</sub>* in early-stage progressive supranuclear palsy variants
Vincent Beliveau, Christoph Müller, Ruth Steiger, et al.
Page
of 61
Search research articles
Search
Showing results (191-200 of 602) with videos related to
Sort By:
Page
of 61
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 27, 2008
Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients
Paolo Barone, David J Burn, Teus van Laar, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 5, 2002
Application of the International Cooperative Ataxia Scale rating in multiple system atrophy
François Tison, Farid Yekhlef, Eric Balestre, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 18, 2011
Restless legs syndrome in Friedreich ataxia: a polysomnographic study
Birgit Frauscher, Sascha Hering, Birgit Högl, et al.
Journal of Neurology
|
September 22, 2006
Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : a double-blind placebo-controlled cross-over trial
Jörg Wissel, Tanja Haydn, Jörg Müller, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 9, 2002
Riluzole therapy in cervical dystonia
Jörg Müller, Gregor K Wenning, Jörg Wissel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 2, 2008
Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: a clinical pilot trial
Sylvia Boesch, Brigitte Sturm, Sascha Hering, et al.
Journal of Neurology
|
March 6, 2007
Progression of brain atrophy in multiple system atrophy. A longitudinal VBM study
Christian Brenneis, Karl Egger, Christoph Scherfler, et al.
Movement Disorders Clinical Practice
|
October 27, 2018
Elastic Abdominal Binders Attenuate Orthostatic Hypotension in Parkinson's Disease
Alessandra Fanciulli, Georg Goebel, Bernhard Metzler, et al.
Expert Review of Neurotherapeutics
|
February 2, 2023
Optimizing levodopa therapy, when and how? Perspectives on the importance of delivery and the potential for an early combination approach
Andrew Lees, Eduardo Tolosa, Fabrizio Stocchi, et al.
Parkinsonism & Related Disorders
|
July 6, 2022
Characterization and diagnostic potential of R<sub>2</sub>* in early-stage progressive supranuclear palsy variants
Vincent Beliveau, Christoph Müller, Ruth Steiger, et al.
Page
of 61